Novartis heart drug gets FDA's 'breakthrough' status

ZURICH (Reuters) - Swiss pharmaceuticals company Novartis said on Friday U.S. regulators have given breakthrough therapy status to an investigational treatment for patients with acute heart failure, potentially fast tracking its development and approval.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/P3f48T8YZAY/story01.htm

phlebotomy training in nyc phlebotomy training in va phlebotomy certification in nj